Dr. Sinvhal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9 Treetops Cir
Princeton, NJ 08540Phone+1 732-485-7820
Education & Training
Atlantic Health System/Overlook Medical CenterResidency, Internal Medicine, 1998 - 2002
Government Medical College NagpurClass of 1996
Certifications & Licensure
CA State Medical License 2022 - 2026
NJ State Medical License 2002 - 2023
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Efficacy and safety of risankizumab versus methotrexate in patients with moderate-to-severe plaque psoriasis: results from IMMbrace, a randomized, double-blind, phase ...Tania F Cestari, Cacilda da Silva Souza, Luna Azulay-Abulafia, Ricardo Romiti, André V E Carvalho
Anais Brasileiros De Dermatologia. 2024-12-07 - A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis.Andrew F Alexis, Melinda Gooderham, Shawn G Kwatra, Ahmad Amin, Susan Taylor
Dermatology and Therapy. 2024-10-01 - 3 citationsLong-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.Kenneth B Gordon, Andrew Blauvelt, Hervé Bachelez, Laura C Coates, Filip E Van den Bosch
Dermatology and Therapy. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
